Study suggests broccoli may reduce cancer risk

Flag­ship Pi­o­neer­ing, the sprawl­ing life sci­ences in­vestor and start­up in­cu­ba­tor, ap­pears to be seek­ing more cap­i­tal than orig­i­nal­ly planned for its eighth fund. The Boston

APN401 was developed using the cell therapy platform to target Cbl-b class of proteins, which play an inhibitory role in mediating immune response against cancer